IL295911A - Tunable degradation in hydrogel microparticles - Google Patents

Tunable degradation in hydrogel microparticles

Info

Publication number
IL295911A
IL295911A IL295911A IL29591122A IL295911A IL 295911 A IL295911 A IL 295911A IL 295911 A IL295911 A IL 295911A IL 29591122 A IL29591122 A IL 29591122A IL 295911 A IL295911 A IL 295911A
Authority
IL
Israel
Prior art keywords
microparticles
hydrogel
cells
pegda
meha
Prior art date
Application number
IL295911A
Other languages
English (en)
Hebrew (he)
Original Assignee
Likarda Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Likarda Llc filed Critical Likarda Llc
Publication of IL295911A publication Critical patent/IL295911A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Colloid Chemistry (AREA)
IL295911A 2019-06-07 2020-06-05 Tunable degradation in hydrogel microparticles IL295911A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962858578P 2019-06-07 2019-06-07
PCT/US2020/036361 WO2020247776A1 (en) 2019-06-07 2020-06-05 Tunable degradation in hydrogel microparticles

Publications (1)

Publication Number Publication Date
IL295911A true IL295911A (en) 2022-10-01

Family

ID=73652291

Family Applications (1)

Application Number Title Priority Date Filing Date
IL295911A IL295911A (en) 2019-06-07 2020-06-05 Tunable degradation in hydrogel microparticles

Country Status (9)

Country Link
US (1) US12551449B2 (https=)
EP (1) EP3980075A4 (https=)
JP (1) JP7636801B2 (https=)
KR (1) KR20220019261A (https=)
CN (2) CN113924122B (https=)
AU (1) AU2020288650B2 (https=)
CA (1) CA3134372A1 (https=)
IL (1) IL295911A (https=)
WO (1) WO2020247776A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230129007A (ko) * 2020-10-28 2023-09-05 뉴욕 쏘사이어티 포 더 릴리프 어브 더 럽쳐드 앤드 크리플드 메인테이닝 더 하스피틀 포 스페셜 설져리 조직 손상 및 상처에서 영양 유지 및 노폐물 제거를 위한 방법 및 조성물
KR20230119170A (ko) * 2020-12-09 2023-08-16 리카다, 엘엘씨 하이드로겔 마이크로입자 기반 윤활제
WO2022170012A1 (en) * 2021-02-08 2022-08-11 The Trustees Of Indiana University Synthesis of peg-based thiol-norbornene hydrogels with tunable hydroylitic degradation properties
KR20240018511A (ko) * 2021-05-26 2024-02-13 조지아 테크 리서치 코포레이션 가수분해성 하이드로겔 및 이의 용도
US20250001049A1 (en) * 2021-10-15 2025-01-02 Prohibix Llc Bulking and collagen stimulating hydrogel compositions
WO2023106271A1 (ja) * 2021-12-06 2023-06-15 株式会社リコー ハイドロゲル、インクジェット用インク、細胞培養体の作製方法、細胞含有ゲル粒子及びその製造方法
US20240026088A1 (en) 2022-07-19 2024-01-25 CellDrop Biosciences, Inc. Hydrogel Particle Encapsulation and Suspension Media Removal
WO2024173668A1 (en) * 2023-02-17 2024-08-22 Ocular Therapeutix, Inc. Biodegradable microparticles for sustained drug delivery, methods of preparation and use thereof
KR102844193B1 (ko) * 2024-02-07 2025-08-13 주식회사 알데바 지방 조직 유사 구조체 형성용 조성물 및 지방 조직 유사 구조체의 제조방법
US20250319098A1 (en) * 2024-02-21 2025-10-16 Vitalte Lifesciences Inc. Hormone replenishment method with a hydrogel polymer
CN119258009A (zh) * 2024-09-30 2025-01-07 山东大学 一种促进dha胞内降脂的水凝胶材料及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276251B2 (en) 1997-04-01 2007-10-02 Lg Life Sciences, Ltd., Inc. Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
WO2002030481A1 (en) 2000-10-10 2002-04-18 Massachusetts Institute Of Technology Cell delivery using controllably degradable mesh-gel constructs
CN101448527B (zh) 2006-05-19 2013-12-18 香港大学 细胞-基质微球，制备方法和应用
US20080193536A1 (en) * 2006-08-14 2008-08-14 Alireza Khademhosseini Cell-Laden Hydrogels
US20100069781A1 (en) * 2008-04-15 2010-03-18 Johansen Jerald A Device and method for accessing and treating ducts of mammary glands
KR101101321B1 (ko) 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
CA2769162C (en) * 2009-07-31 2017-12-05 Ascendis Pharma As Biodegradable polyethylene glycol based water-insoluble hydrogels
US10647959B2 (en) 2011-04-27 2020-05-12 President And Fellows Of Harvard College Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
SG11201500188YA (en) * 2012-08-08 2015-02-27 Univ Nanyang Tech Methods of manufacturing hydrogel microparticles having living cells, and compositions for manufacturing a scaffold for tissue engineering
US9381217B2 (en) * 2013-09-09 2016-07-05 Georgia Tech Research Corporation Microgels for encapsulation of cells and other biologic agents
CN106470666B (zh) * 2014-06-04 2021-01-01 立卡达有限责任公司 微囊封装技术及其产品
WO2015187098A1 (en) 2014-06-05 2015-12-10 Agency For Science, Technology And Research Material and structures for cell delivery
US20160297131A1 (en) 2015-04-07 2016-10-13 The Texas A&M University System Hydrogel Microparticles via Soft Robotics Micromold (SRM) for In Vitro Cell Culture
US10137082B2 (en) 2016-08-22 2018-11-27 Washington University Hydrogel microparticle scaffold with gradients of degradability and methods thereof
JP2022513378A (ja) 2018-10-26 2022-02-07 テサラ・セラピューティクス・ピーティーワイ・リミテッド 神経系細胞療法
US20220175666A1 (en) 2019-03-21 2022-06-09 Anterogen Co., Ltd. Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same
EP4284338A4 (en) 2021-02-01 2024-12-04 The Regents Of The University Of Colorado, A Body Corporate COMPOSITIONS AND METHODS OF MAKING AND USING HYBRID NETWORK HYDROGELS

Also Published As

Publication number Publication date
AU2020288650B2 (en) 2025-12-11
KR20220019261A (ko) 2022-02-16
US12551449B2 (en) 2026-02-17
EP3980075A1 (en) 2022-04-13
AU2020288650A1 (en) 2021-12-09
EP3980075A4 (en) 2023-07-12
JP7636801B2 (ja) 2025-02-27
JP2022534787A (ja) 2022-08-03
CN113924122B (zh) 2025-08-12
CN120938958A (zh) 2025-11-14
CN113924122A (zh) 2022-01-11
WO2020247776A1 (en) 2020-12-10
CA3134372A1 (en) 2020-12-10
US20220233454A1 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
AU2020288650B2 (en) Tunable degradation in hydrogel microparticles
Yang et al. Injectable chitin hydrogels with self-healing property and biodegradability as stem cell carriers
CA2625875C (en) Encapsulation system
ES2895947T3 (es) Composición y conjuntos para matrices de microgel pseudoplástico
Fan et al. Cytocompatible in situ forming chitosan/hyaluronan hydrogels via a metal-free click chemistry for soft tissue engineering
Hamilton et al. Hyaluronic acid hydrogel microspheres for slow release stem cell delivery
US20200253192A1 (en) Zwitterionic microgels, their assemblies and related formulations, and methods for their use
CN116615263A (zh) 水凝胶微粒基润滑剂
CN118718089A (zh) 一种可注射脂肪脱细胞生物材料及其制备方法
JP7809907B2 (ja) 膨潤性ゼラチン組成物
EP4582439A1 (en) Method for obtainingmethod for obtaining a porous injectable scaffold based on similar biopolymers with different melting temperatures
김수진 Development of hydrogel scaffolds for adipose tissue regeneration
US20120003192A1 (en) Hydrogel-forming composition comprising protein and non-protein segments
EA048072B1 (ru) Способная к набуханию желатиновая фармацевтическая композиция, набухшая желатиновая фармацевтическая композиция, способы их получения и варианты их применения
CN121588279A (zh) 自组装三维组织及治疗剂递送的方法
Lv et al. Microcapsules for Cell Transplantation: Design, Preparation, and Application
HK1173180A (en) Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products